Evidence map›Paper›PMID 25902709›Full record

ReviewPediatric rheumatology online journal2015

Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.

Reut Gurion, Vin Tangpricha, Eric Yow, Laura E Schanberg, Grace A McComsey, Angela Byun Robinson, Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Pediatric rheumatology online journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00065806 (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00065806 phase3completednot on this map

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor (Atorvastatin) in Reducing the Progression of Carotid IMT in Early Childhood SLE

TypeinterventionalSponsorLaura SchanbergRan2003 to 2009Enrolled221ConditionsLupus Erythematosus, SystemicArmsAtorvastatin, Placebo atorvastatin
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Risk Factors for Corticosteroid-associated Osteonecrosis in Children: A National Database Study.Journal of the Pediatric Orthopaedic Society of North America · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Utility of SPECT/CT in Non-Traumatic Osteonecrosis: Revisited with New Insights from a Prospective Diagnostic Study.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Reut GurionDivision of Pediatric Infectious Diseases, Rheumatology and Global Health, Department of Pediatrics, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH, USA. reut.gurion@uhhospitals.org.
Vin TangprichaDivision of Endocrinology, Metabolism & Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. vin.tangpricha@emory.edu.
Eric YowDuke Clinical Research Institute, Durham, North Carolina, USA. eric.yow@duke.edu.
Laura E SchanbergDivision of Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 27710, USA. laura.schanberg@duke.edu.
Grace A McComseyDivision of Pediatric Infectious Diseases, Rheumatology and Global Health, Department of Pediatrics, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH, USA. grace.mccomsey@case.edu.
Angela Byun RobinsonDivision of Pediatric Infectious Diseases, Rheumatology and Global Health, Department of Pediatrics, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH, USA. angela.robinson@uhhospitals.org.
Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
Duke University · USEmory University · USRainbow Babies & Children's Hospital · USUniversity Hospitals Cleveland Medical Center · US

Funding

ROLE OF ANGPTL4, AN ANGIOGENIC MEDIATOR, IN ARTHRITISP30AR047363 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI THOMPSON, SUSAN D · 2001 to 2015
$9.2M
PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PEDIATRIC SYSTEMIC LUPUS-264022265N01AR022265 · NIAMS · DUKE UNIVERSITY MEDICAL CTR. · PI SCHANBERG, LAURA E · 2002 to 2006
–
NIAMS NIH HHS 5P30-AR-047363-12NIAMS NIH HHS N01-AR-2-2265NIAMS NIH HHS P30 AR047363
6 · The paper itself

Abstract

unlabelledAvascular necrosis (AVN) occurs in several chronic illnesses, including systemic lupus erythematosus (SLE), but can also occur in healthy children. There are multiple theories to explain why and how AVN occurs, but an exact mechanism has yet to be unraveled. AVN in the pediatric lupus population is understudied. The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) trial, provides an excellent venue to conduct an exploratory analysis to assess associations between AVN and demographics, SLE disease activity and vitamin D deficiency. Herein we present a brief report describing our findings, as well as reviewing the literature on AVN in SLE and other entities.

trial registrationClinicalTrials.gov identifier: NCT00065806.

Indexed as

Cell- and Tissue-Based TherapyChildDiphosphonatesHumansLupus Erythematosus, SystemicOrthopedicsOsteonecrosisSeverity of Illness IndexVasodilator AgentsVitamin D DeficiencyDiphosphonatesVasodilator Agents

Identifiers

PMID25902709
PMCPMC4415214
OpenAlexW2117463604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.